Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiaoaiping injection for platelet protection during chemotherapy in lung or gastric cancer
ChiCTR-TRC-13003888Phase 4Completed
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Dec 2013
- Countries
- 1
01
Overview
Phase 4, open-label trial of xiaoaiping in non-small cell lung cancer (NSCLC) and gastric cancer (GC) (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Platelet count, Mean platelet volume and 2 more. Started Dec 2013; status: completed.
02
Drugs
xiaoaiping
03
Conditions
non-small cell lung cancer (NSCLC)gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR-TRC-13003888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003888.